This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Alferon LDO

Hemispherx Biopharma, Inc.

Drug Names(s): Interferon alpha-n3 Low Dose Oral

Description: Alferon LDO is a Low Dose Oral formulation of interferon alpha-n3 derived from human leukocytes. Interferons are natural proteins produced by leukocytes, in response to viral pathogens, to combat infection.

Alferon LDO News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug